Genitourinary Radiology: Page 17

C-11 choline PET/MRI helps restage prostate cancer patients

By Wayne Forrest

A preliminary study by German researchers suggests that carbon-11 (C-11) choline PET/MRI may provide an alternative imaging modality to PET/CT for restaging of prostate cancer by offering equal, if not better, diagnostic performance and less radiation exposure.

January 16, 2013

Urology residents lack awareness of radiation exposure

By Cynthia E. Keen

Urology residents in Europe are shockingly unaware of the dangers of radiation exposure and the importance of using radiation protection when performing fluoroscopy-guided endourologic procedures, if results from a survey of members of the European Society of Residents in Urology are indicative of the group.

January 6, 2013

CADx may improve diagnosis of central gland prostate cancer

By Erik L. Ridley

Computer-aided diagnosis (CADx) shows potential as a tool to aid radiologists in the challenging task of finding cancer originating from the prostate's central gland, according to Dutch research presented at the 2012 RSNA meeting in Chicago.

December 9, 2012

Mauna's UroFlex receives CE Mark

By AuntMinnieEurope.com staff writers

Mauna Kea Technologies' UroFlex confocal miniprobe has received CE Mark approval for use during cystoscopy procedures.

December 6, 2012

10-year prostate cancer outcomes show rad therapy's benefit

By Cynthia E. Keen

Ten-year clinical outcomes for prostate cancer patients participating in a trial comparing postoperative radiotherapy with observation only show that patients who were irradiated had significantly improved biochemical progression-free survival and local control.

October 18, 2012

SNM: New therapy extends life for prostate cancer patients

By AuntMinnieEurope.com staff writers

Survival is bleak for prostate cancer patients with advanced tumors that have spread to the bone, but a radioisotope procedure being evaluated in a clinical trial is extending lives by several months, according to a study presented at the Society of Nuclear Medicine (SNM) annual meeting, being held in Miami Beach, FL, this week.

June 10, 2012

Accuray begins PACE prostate study

By AuntMinnieEurope.com staff writers

Radiation therapy firm Accuray has launched the Prostate Advances in Comparative Evidence (PACE) study.

April 26, 2012

USHIFU puts emphasis on Lancet study results

By AuntMinnieEurope.com staff writers

High-intensity focused ultrasound (HIFU) developer USHIFU is is emphasizing study results study results published online in Lancet Oncology.

April 17, 2012

BMJ casts doubt on proton therapy for prostate cancer

By AuntMinnieEurope.com staff writers

There is no clear evidence of proton beam therapy's effectiveness in treating prostate cancer, according to a feature published online on 17 April in the British Medical Journal (BMJ).

April 16, 2012

ESUR issues new guidance on best use of prostate MRI

By Philip Ward

As a first step toward the greater standardization of prostate imaging, the European Society of Urogenital Radiology (ESUR) has published a guideline for MRI of the prostate. The ESUR Prostate Working Group has developed a structured reporting system, called PI-RADS (prostate imaging, reporting, and data system).

February 23, 2012

Choline-PET/CT changes prostate cancer treatment plans

By Wayne Forrest

Swiss researchers have found that PET/CT scans with the radiopharmaceutical choline can change treatment plans for certain patients with recurrent prostate cancer. Study results showed that choline-PET/CT significantly affected therapy management.

February 13, 2012

External radiation plus high-dose brachytherapy effective for high-risk prostate cancer

By Reuters Health

NEW YORK (Reuters Health) - Ten-year survival rates are high when patients with unfavorable localized prostate cancer are treated with external-beam radiotherapy boosted with conformal high-dose-rate brachytherapy, a Spanish group reports.

November 28, 2011

Previous Page

Page 17 of 22

Next Page